senate Bill S5450A

2011-2012 Legislative Session

Establishes the sickle cell treatment act of 2012

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Committee


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

do you support this bill?

Actions

view actions (6)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Mar 19, 2012 committee discharged and committed to rules
notice of committee consideration - requested
Jan 05, 2012 print number 5450a
amend (t) and recommit to social services
Jan 04, 2012 referred to social services
May 24, 2011 referred to social services

Bill Amendments

Original
A (Active)
Original
A (Active)

S5450 - Details

See Assembly Version of this Bill:
A8022A
Current Committee:
Law Section:
Social Services Law
Laws Affected:
Amd §365, add §363-f, Soc Serv L

S5450 - Summary

Establishes the sickle cell treatment act of 2012.

S5450 - Sponsor Memo

S5450 - Bill Text download pdf

                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  5450

                       2011-2012 Regular Sessions

                            I N  S E N A T E

                              May 24, 2011
                               ___________

Introduced  by  Sen. HUNTLEY -- read twice and ordered printed, and when
  printed to be committed to the Committee on Social Services

AN ACT to amend the social services law, in relation to establishing the
  sickle cell treatment act of 2011

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.  This  act  shall be known and may be cited as the "sickle
cell treatment act of 2011".
  S 2. Legislative findings. The legislature hereby finds  and  declares
the following:
  (1)  Sickle  cell  disease  (SCD) is an inherited disease of red blood
cells that is a major health problem in the United States.
  (2) Approximately 70,000 Americans have SCD  and  approximately  1,800
American  babies  are  born  with  the  disease each year. SCD also is a
global problem with close to  300,000  babies  born  annually  with  the
disease.
  (3)  In the United States, SCD is most common in African-Americans and
in those of Hispanic, Mediterranean, and Middle Eastern ancestry.  Among
newborn  American infants, SCD occurs in approximately 1 in 300 African-
Americans, 1 in 36,000 Hispanics, and 1 in 80,000 Caucasians.
  (4) More than 2,500,000 Americans, mostly African-Americans, have  the
sickle  cell  trait.  These Americans are healthy carriers of the sickle
cell gene who have inherited the normal hemoglobin gene from one  parent
and  the sickle gene from the other parent. A sickle cell trait is not a
disease, but when both parents have the sickle cell trait, there is a  1
in 4 chance with each pregnancy that the child will be born with SCD.
  (5)  Children  with SCD may exhibit frequent pain episodes, entrapment
of blood within the spleen, severe anemia, acute lung complications, and
priapism. During episodes of severe pain, spleen enlargement,  or  acute
lung  complications, life threatening complications can develop rapidly.
Children with SCD are also  at  risk  for  septicemia,  meningitis,  and

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD11759-01-1

Co-Sponsors

S5450A (ACTIVE) - Details

See Assembly Version of this Bill:
A8022A
Current Committee:
Law Section:
Social Services Law
Laws Affected:
Amd §365, add §363-f, Soc Serv L

S5450A (ACTIVE) - Summary

Establishes the sickle cell treatment act of 2012.

S5450A (ACTIVE) - Sponsor Memo

S5450A (ACTIVE) - Bill Text download pdf

                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 5450--A

                       2011-2012 Regular Sessions

                            I N  S E N A T E

                              May 24, 2011
                               ___________

Introduced  by  Sen. HUNTLEY -- read twice and ordered printed, and when
  printed to be committed to the Committee on Social Services --  recom-
  mitted  to  the Committee on Social Services in accordance with Senate
  Rule  6,  sec.  8  --  committee  discharged,  bill  amended,  ordered
  reprinted as amended and recommitted to said committee

AN ACT to amend the social services law, in relation to establishing the
  sickle cell treatment act of 2012

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. This act shall be known and may be  cited  as  the  "sickle
cell treatment act of 2012".
  S  2.  Legislative findings. The legislature hereby finds and declares
the following:
  (1) Sickle cell disease (SCD) is an inherited  disease  of  red  blood
cells that is a major health problem in the United States.
  (2)  Approximately  70,000  Americans have SCD and approximately 1,800
American babies are born with the disease  each  year.  SCD  also  is  a
global  problem  with  close  to  300,000  babies born annually with the
disease.
  (3) In the United States, SCD is most common in African-Americans  and
in  those of Hispanic, Mediterranean, and Middle Eastern ancestry. Among
newborn American infants, SCD occurs in approximately 1 in 300  African-
Americans, 1 in 36,000 Hispanics, and 1 in 80,000 Caucasians.
  (4)  More than 2,500,000 Americans, mostly African-Americans, have the
sickle cell trait. These Americans are healthy carriers  of  the  sickle
cell  gene who have inherited the normal hemoglobin gene from one parent
and the sickle gene from the other parent. A sickle cell trait is not  a
disease,  but when both parents have the sickle cell trait, there is a 1
in 4 chance with each pregnancy that the child will be born with SCD.
  (5) Children with SCD may exhibit frequent pain  episodes,  entrapment
of blood within the spleen, severe anemia, acute lung complications, and

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD11759-02-1

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.